BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 26149442)

  • 1. Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.
    Steiner C; Tille JC; Lamerz J; Kux van Geijtenbeek S; McKee TA; Venturi M; Rubbia-Brandt L; Hochstrasser D; Cutler P; Lescuyer P; Ducret A
    Mol Cell Proteomics; 2015 Oct; 14(10):2786-99. PubMed ID: 26149442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.
    Kennedy JJ; Whiteaker JR; Kennedy LC; Bosch DE; Lerch ML; Schoenherr RM; Zhao L; Lin C; Chowdhury S; Kilgore MR; Allison KH; Wang P; Hoofnagle AN; Baird GS; Paulovich AG
    Clin Chem; 2021 Jul; 67(7):1008-1018. PubMed ID: 34136904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue.
    Sprung RW; Martinez MA; Carpenter KL; Ham AJ; Washington MK; Arteaga CL; Sanders ME; Liebler DC
    J Proteome Res; 2012 Jun; 11(6):3498-505. PubMed ID: 22530795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays.
    Steiner C; Lescuyer P; Cutler P; Tille JC; Ducret A
    Mol Cell Proteomics; 2022 Nov; 21(11):100416. PubMed ID: 36152753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy.
    Do M; Kim H; Yeo I; Lee J; Park IA; Ryu HS; Kim Y
    Clin Chem; 2020 Oct; 66(10):1339-1348. PubMed ID: 33001186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Highly Multiplexed SRM Assay for Biomarker Discovery in Formalin-Fixed Paraffin-Embedded Tissues.
    Steiner C; Lescuyer P; Tille JC; Cutler P; Ducret A
    Methods Mol Biol; 2019; 1959():185-203. PubMed ID: 30852824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue.
    Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Hewitt SM; Bender RA; Krizman DB; Burrows J
    J Mol Diagn; 2013 Jul; 15(4):454-65. PubMed ID: 23672976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
    Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for HER2 FISH determination on PAXgene-fixed and paraffin-embedded tissue in breast cancer.
    Oberauner-Wappis L; Loibner M; Viertler C; Groelz D; Wyrich R; Zatloukal K
    Int J Exp Pathol; 2016 Apr; 97(2):202-6. PubMed ID: 27273709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2.
    Jensen K; Krusenstjerna-Hafstrøm R; Lohse J; Petersen KH; Derand H
    Mod Pathol; 2017 Feb; 30(2):180-193. PubMed ID: 27767098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
    Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues.
    Kennedy JJ; Whiteaker JR; Schoenherr RM; Yan P; Allison K; Shipley M; Lerch M; Hoofnagle AN; Baird GS; Paulovich AG
    J Proteome Res; 2016 Aug; 15(8):2717-28. PubMed ID: 27462933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients.
    Sperinde J; Jin X; Banerjee J; Penuel E; Saha A; Diedrich G; Huang W; Leitzel K; Weidler J; Ali SM; Fuchs EM; Singer CF; Köstler WJ; Bates M; Parry G; Winslow J; Lipton A
    Clin Cancer Res; 2010 Aug; 16(16):4226-35. PubMed ID: 20664024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Usefulness of a One-Tube Nested Reverse Transcription Quantitative Polymerase Chain Reaction Assay for Evaluating Human Epidermal Growth Factor Receptor 2 mRNA Overexpression in Formalin-Fixed and Paraffin-Embedded Breast Cancer Tissue Samples.
    Wang HY; Ahn S; Park S; Kim S; Lee H
    Pathobiology; 2017; 84(2):57-70. PubMed ID: 27544315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation Ratio Determination in Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Tissue with Targeted Mass Spectrometry.
    Zeneyedpour L; Stingl C; Dekker LJM; Mustafa DAM; Kros JM; Luider TM
    J Proteome Res; 2020 Oct; 19(10):4179-4190. PubMed ID: 32811146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T; Guo P; Qiu Y; Chen S; Yang L; Sun L; Ye F; Bu H
    Int J Clin Exp Pathol; 2015; 8(9):10565-74. PubMed ID: 26617766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).
    Kiyose S; Igarashi H; Nagura K; Kamo T; Kawane K; Mori H; Ozawa T; Maeda M; Konno K; Hoshino H; Konno H; Ogura H; Shinmura K; Hattori N; Sugimura H
    Pathol Int; 2012 Nov; 62(11):728-34. PubMed ID: 23121603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
    Kobayashi M; Ooi A; Oda Y; Nakanishi I
    Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Human Epidermal Growth Factor Receptor 2 (HER2) Gene Status in Human Breast Cancer Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens by Fluorescence In Situ Hybridization (FISH).
    Hwang HC; Gown AM
    Methods Mol Biol; 2016; 1406():61-70. PubMed ID: 26820945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.